Open AccessIron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
Author(s) -
Vineet Mishra,
Ruchika Verneker,
Khushali Gandhi,
Sumesh Choudhary,
Sunita Lamba
Publication year - 2018
Publication title -
journal of mid-life health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.423
H-Index - 11
eISSN - 0976-7819
pISSN - 0976-7800
DOI - 10.4103/jmh.jmh_121_17
Subject(s) - medicine , anemia , adverse effect , blood transfusion , hemoglobin , iron deficiency anemia , iron deficiency , surgery , gastroenterology , pediatrics
Menstrual disorder accounts for 5%-10% of the women presenting with iron deficiency anemia (IDA) in the perimenopausal age group. Heavy menstrual bleeding in this age group leads to severe anemia and frequently requires blood transfusion which has its own adverse effects. We today have ferric carboxymaltose (FCM) as a safer alternative to blood transfusion.